Kovács, P.T.; Mayer, T.; Csizmarik, A.; Váradi, M.; Oláh, C.; Széles, Á.; Tschirdewahn, S.; Krafft, U.; Hadaschik, B.; Nyirády, P.;
et al. Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. Biomedicines 2022, 10, 698.
https://doi.org/10.3390/biomedicines10030698
AMA Style
Kovács PT, Mayer T, Csizmarik A, Váradi M, Oláh C, Széles Á, Tschirdewahn S, Krafft U, Hadaschik B, Nyirády P,
et al. Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. Biomedicines. 2022; 10(3):698.
https://doi.org/10.3390/biomedicines10030698
Chicago/Turabian Style
Kovács, Petra Terézia, Tamás Mayer, Anita Csizmarik, Melinda Váradi, Csilla Oláh, Ádám Széles, Stephan Tschirdewahn, Ulrich Krafft, Boris Hadaschik, Péter Nyirády,
and et al. 2022. "Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma" Biomedicines 10, no. 3: 698.
https://doi.org/10.3390/biomedicines10030698
APA Style
Kovács, P. T., Mayer, T., Csizmarik, A., Váradi, M., Oláh, C., Széles, Á., Tschirdewahn, S., Krafft, U., Hadaschik, B., Nyirády, P., Riesz, P., & Szarvas, T.
(2022). Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma. Biomedicines, 10(3), 698.
https://doi.org/10.3390/biomedicines10030698
